NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
JRCT ID: jRCTs031190087

Registered date:01/09/2019

Evaluation of the effect of preprandial ingestion of novel glucomannan containing food on human health.

Basic Information

Recruitment status Complete
Health condition(s) or Problem(s) studiedhealthy subjects or diabetes mellitus controlled under HbA1c 7.0% (NGSP)
Date of first enrollment29/09/2019
Target sample size20
Countries of recruitment
Study typeInterventional
Intervention(s)1st time: taking TRELAN G75 225ml 2nd time: after taking G1 fiber or placebo, taking Meas Test S allowing 200ml water

Outcome(s)

Primary OutcomeSuppression of the elevation of plasma glucose
Secondary OutcomeSuppression of the elevation of insulin and elevation of incretin

Key inclusion & exclusion criteria

Age minimum>= 20age old
Age maximum<= 60age old
GenderMale
Include criteriahealthy subjects or diabetes patients with HbA1c <7%
Exclude criteriadiabetes patients with HbA1c >= 7% diabetes patients under treatment patients with severe constipation

Related Information

Contact

Public contact
Name Akihiro Yoshida
Address 3-39-15, Showamachi, Maebashi-shi, Gunma Gunma Japan 371-8511
Telephone +81-27-220-8576
E-mail ayossie10@gunma-u.ac.jp
Affiliation Gunma University Hospital
Scientific contact
Name Akihiro Yoshida
Address 3-39-15, Showamachi, Maebashi-shi, Gunma Gunma Japan 371-8511
Telephone +81-27-220-8576
E-mail ayossie10@gunma-u.ac.jp
Affiliation Gunma University Hospital